APA (7th ed.) Citation

M, K., T, K., Y, N., A, M., H, T., & K, E. (2023). Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 34(3), 563. https://doi.org/10.1007/s00198-022-06642-1

Chicago Style (17th ed.) Citation

M, Kashii, Kamatani T, Nagayama Y, Miyama A, Tsuboi H, and Ebina K. "Baseline Serum PINP Level Is Associated with the Increase in Hip Bone Mineral Density Seen with Romosozumab Treatment in Previously Untreated Women with Osteoporosis." Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 34, no. 3 (2023): 563. https://doi.org/10.1007/s00198-022-06642-1.

MLA (9th ed.) Citation

M, Kashii, et al. "Baseline Serum PINP Level Is Associated with the Increase in Hip Bone Mineral Density Seen with Romosozumab Treatment in Previously Untreated Women with Osteoporosis." Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, vol. 34, no. 3, 2023, p. 563, https://doi.org/10.1007/s00198-022-06642-1.